Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective

Ductal carcinoma in situ (DCIS) is encountered much more frequently in the screening population compared to the symptomatic setting. The behaviour of DCIS is highly variable and this presents difficulties in choosing appropriate treatment strategies for individual cases. This review discusses the cu...

Descripción completa

Detalles Bibliográficos
Autor principal: Jones, J Louise
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557717/
https://www.ncbi.nlm.nih.gov/pubmed/16677423
http://dx.doi.org/10.1186/bcr1397
_version_ 1782129396239302656
author Jones, J Louise
author_facet Jones, J Louise
author_sort Jones, J Louise
collection PubMed
description Ductal carcinoma in situ (DCIS) is encountered much more frequently in the screening population compared to the symptomatic setting. The behaviour of DCIS is highly variable and this presents difficulties in choosing appropriate treatment strategies for individual cases. This review discusses the current data on the frequency and rate of progression of DCIS, the value and limitations of clinicopathological and biological variables in predicting disease behaviour and suggests strategies to develop more robust means of predicting progression of DCIS.
format Text
id pubmed-1557717
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15577172006-09-01 Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective Jones, J Louise Breast Cancer Res Review Ductal carcinoma in situ (DCIS) is encountered much more frequently in the screening population compared to the symptomatic setting. The behaviour of DCIS is highly variable and this presents difficulties in choosing appropriate treatment strategies for individual cases. This review discusses the current data on the frequency and rate of progression of DCIS, the value and limitations of clinicopathological and biological variables in predicting disease behaviour and suggests strategies to develop more robust means of predicting progression of DCIS. BioMed Central 2006 2006-04-21 /pmc/articles/PMC1557717/ /pubmed/16677423 http://dx.doi.org/10.1186/bcr1397 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Review
Jones, J Louise
Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective
title Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective
title_full Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective
title_fullStr Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective
title_full_unstemmed Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective
title_short Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective
title_sort overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557717/
https://www.ncbi.nlm.nih.gov/pubmed/16677423
http://dx.doi.org/10.1186/bcr1397
work_keys_str_mv AT jonesjlouise overdiagnosisandovertreatmentofbreastcancerprogressionofductalcarcinomainsituthepathologicalperspective

Ejemplares similares